tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thomas Shrader, 115 are a BUY (88.46%), 13 are a HOLD (10%), 2 are a SELL (1.54%).
Analyst Thomas Shrader, currently employed at BTIG, carries an average stock price target met ratio of 47.84% that have a potential upside of 45.12% achieved within 212 days.
Thomas Shrader’s has documented 245 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRNA, Verona Pharma PLC ADR at 10-Jul-2025.
Analyst best performing recommendations are on VRNA (VERONA PHARMA PLC ADR).
The best stock recommendation documented was for VRNA (VERONA PHARMA PLC ADR) at 12/20/2022. The price target of $26 was fulfilled within 10 days with a profit of $7.41 (39.86%) receiving and performance score of 39.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$67
$20.53 (44.18%)
$49
3 days ago
(10-Jul-2025)
3/5 (60%)
$20.53 (44.18%)
294
Buy
$54
$7.53 (16.20%)
$45
19 days ago
(24-Jun-2025)
5/7 (71.43%)
$9.62 (21.68%)
191
Buy
$56
$9.53 (20.51%)
$53
1 months 5 days ago
(08-Jun-2025)
16/25 (64%)
$16.97 (43.48%)
310
Buy
$72
$25.53 (54.94%)
$54
2 months 14 days ago
(29-Apr-2025)
2/6 (33.33%)
$33.64 (87.70%)
334
Buy
$55
$8.53 (18.36%)
$52
2 months 14 days ago
(29-Apr-2025)
5/8 (62.5%)
$16.64 (43.38%)
227
Which stock is Thomas Shrader is most bullish on?
What Year was the first public recommendation made by Thomas Shrader?
